These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33642219)

  • 21. Microbiome and Retinal Vascular Diseases.
    Lincke JB; Christe L; Unterlauft JD; Zinkernagel MS; Zysset-Burri DC
    Am J Pathol; 2023 Nov; 193(11):1675-1682. PubMed ID: 36963629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome and cardiovascular disease.
    Zhao Y; Wang Z
    Curr Opin Cardiol; 2020 May; 35(3):207-218. PubMed ID: 32068612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Dysbiosis in Animals Due to Environmental Chemical Exposures.
    Rosenfeld CS
    Front Cell Infect Microbiol; 2017; 7():396. PubMed ID: 28936425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The gut microbiome and thromboembolism.
    Hasan RA; Koh AY; Zia A
    Thromb Res; 2020 May; 189():77-87. PubMed ID: 32192995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport.
    Jiang Y; Pang S; Liu X; Wang L; Liu Y
    J Cardiovasc Transl Res; 2024 Jun; 17(3):624-637. PubMed ID: 38231373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity, diabetes, and the gut microbiome: an updated review.
    Singer-Englar T; Barlow G; Mathur R
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):3-15. PubMed ID: 30791839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.
    Sanchez-Rodriguez E; Egea-Zorrilla A; Plaza-Díaz J; Aragón-Vela J; Muñoz-Quezada S; Tercedor-Sánchez L; Abadia-Molina F
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiome and cardiometabolic risk.
    Kappel BA; Federici M
    Rev Endocr Metab Disord; 2019 Dec; 20(4):399-406. PubMed ID: 31836950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story.
    Inceu AI; Neag MA; Craciun AE; Buzoianu AD
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.
    Kiouptsi K; Reinhardt C
    Br J Pharmacol; 2018 Dec; 175(24):4439-4449. PubMed ID: 30129122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact.
    Qamar N; Castano D; Patt C; Chu T; Cottrell J; Chang SL
    Behav Brain Res; 2019 Dec; 376():112196. PubMed ID: 31476330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases.
    Chen J; Guo Y; Gui Y; Xu D
    Lipids Health Dis; 2018 Jan; 17(1):17. PubMed ID: 29357881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut Microbiota, Atherosclerosis, and Therapeutic Targets.
    Mantziaris V; Kolios G
    Crit Pathw Cardiol; 2019 Sep; 18(3):139-142. PubMed ID: 31348074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological Effects of Indole-3-Propionic Acid, a Gut Microbiota-Derived Metabolite, and Its Precursor Tryptophan in Mammals' Health and Disease.
    Konopelski P; Mogilnicka I
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
    Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
    Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gut microbiome and heart failure.
    Ahmad AF; Ward NC; Dwivedi G
    Curr Opin Cardiol; 2019 Mar; 34(2):225-232. PubMed ID: 30575647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.
    Sprouse ML; Bates NA; Felix KM; Wu HJ
    Immunology; 2019 Apr; 156(4):305-318. PubMed ID: 30560993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
    Du Y; Li X; Su C; Wang L; Jiang J; Hong B
    Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
    [No Abstract]   [Full Text] [Related]  

  • 40. Gut Microbiota and Its Metabolites in Atherosclerosis Development.
    Pieczynska MD; Yang Y; Petrykowski S; Horbanczuk OK; Atanasov AG; Horbanczuk JO
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.